HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.

AuthorsC Sessa, S B Kaye, J Renard, W ten Bokkel Huinink, F Cavalli
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 25 Issue 4 Pg. 751-2 (Apr 1989) ISSN: 0277-5379 [Print] England
PMID2523809 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Menogaril
  • Nogalamycin
  • Daunorubicin
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use)
  • Daunorubicin (analogs & derivatives)
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Menogaril
  • Middle Aged
  • Nogalamycin (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
  • Ovarian Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: